Abstract
Objective:
To report a suspected case of subclinical neuroleptic malignant syndrome (NMS) that possibly responded to electroconvulsive therapy.
Case Summary:
A 51-year-old white woman with a history of schizoaffective disorder, depressed type, was admitted to our inpatient unit after presenting with all features of NMS except fever. The patient's symptoms were markedly improved after eight courses of electroconvulsive therapy.
Discussion:
The “spectrum concept” of NMS is increasingly being recognized. More controlled studies are required to understand the components of this syndrome.
Get full access to this article
View all access options for this article.
References
1.
Walker
WD
. Spectrum concept of neuroleptic malignant syndrome
(letter) . Br J Psychiatry
1988 ; 153 : 574 .
2.
Keck
PE
Jr
Caroff
SN
McElroy
SC
. Neuroleptic malignant syndrome and malignant
hyperthermia: End of controversy?
J Neuropsychiatry Clin Neurosci
1995 ; 7 :
135 –44 .
3.
Miyatake
R
Iwahash
K
Matsushita
M
Nakamura
K
Suwaki
H
. No association between the neuroleptic malignant
syndrome and mutations in the RYR1 gene associated malignant
hyperthermia . J Neurol Sci
1996 ; 143 :
161 –5 .
4.Diagnostic and statistical manual of mental disorders . 4th
ed.
Washington, DC : American Psychiatric
Association , 1994 .
5.
Dowling
JJ
Patrick
V
. Delirium with dystonia: A variant of neuroleptic
malignant syndrome . Am J Psychiatry
1989 ; 146 :
276 –7 .
6.
Hynes
AFM
Vickar
EL
. Case study: Neuroleptic malignant syndrome without
pyrexia . J Am Acad Child Adolesc Psychiatry
1996 ; 35 :
959 –62 .
7.
Sullivan
CF
. A possible variant of the neuroleptic malignant
syndrome . Br J Psychiatry
1987 ; 151 :
689 –90 .
8.
Woodbury
MM
Woodbury
MA
. Neuroleptic-induced catatonia as a stage in the
progression toward neuroleptic malignant syndrome . J Am
Acad Child Adolesc Psychiatry
1992 ; 31 :
1161 –4 .
9.
Osman
AA
Khurasani
MH
. Lethal catatonia and neuroleptic malignant syndrome:
A dopamine receptor shut-down hypothesis . Br J
Psychiatry
1994 ; 165 :
548 –50 .
10.
Abbott
RJ
Loizou
LA
. Neuroleptic malignant syndrome .
Br J Psychiatry
1986 ; 148 :
47 –51 .
11.Adityanjee . The myth of elevated
serum Phosphokinase level and neuroleptic malignant syndrome .
Br J Psychiatry
1991 ; 158 :
706 –7 .
12.
Rivera
JM
Garcia-Bragado
F
Iriarte
LM
Lozano
GF
Salgado
V
Andreu
J
Neuroleptic malignant syndrome: Analysis of 9 cases .
Med Clin (Barc)
1990 ; 94 :
121 –5 .
13.
Ebadi
M
Pfeiffer
RF
Murrin
LC
. Pathogenesis and treatment of neuroleptic malignant
syndrome . Gen Pharmacol
1990 ; 21 :
367 –86 .
14.
Hermesh
H
Aizenberg
D
Weizman
A
. A successful electroconvulsive treatment of
neuroleptic malignant syndrome . Acta Psychiatr
Scand
1987 ; 75 :
237 –9 .
15.
Addonizio
G
Susman
VL
. ECT as a treatment alternative for patients with
symptoms of neuroleptic malignant syndrome . J Clin
Psychiatry
1987 ; 48 :
102 –5 .
16.
Caroff
SN
Mann
SC
. Neuroleptic malignant syndrome .
Med Clin North Am
1993 ; 77 :
185 –202 .